Privia Health Group (NASDAQ:PRVA) Sets New 1-Year High - Here's Why

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $25.49 and last traded at $25.47, with a volume of 764095 shares changing hands. The stock had previously closed at $24.87.

Analyst Upgrades and Downgrades

A number of research firms recently commented on PRVA. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Friday, November 29th. Stephens reaffirmed an "overweight" rating and issued a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Needham & Company LLC began coverage on shares of Privia Health Group in a research report on Friday, January 10th. They issued a "buy" rating and a $25.00 target price on the stock. Macquarie began coverage on shares of Privia Health Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $25.00 target price on the stock. Finally, Truist Financial increased their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Friday, November 8th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $24.94.

Privia Health Group Stock Down 0.5 %

The firm has a market cap of $2.94 billion, a PE ratio of 245.22, a P/E/G ratio of 3.59 and a beta of 0.87. The company's fifty day moving average price is $21.99 and its two-hundred day moving average price is $20.40.

Institutional Trading of Privia Health Group

Several hedge funds and other institutional investors have recently made changes to their positions in PRVA. Creative Planning boosted its holdings in shares of Privia Health Group by 27.1% in the third quarter. Creative Planning now owns 25,987 shares of the company's stock valued at $473,000 after acquiring an additional 5,542 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in shares of Privia Health Group by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company's stock valued at $478,000 after purchasing an additional 583 shares during the period. International Assets Investment Management LLC lifted its stake in shares of Privia Health Group by 1,720.9% in the third quarter. International Assets Investment Management LLC now owns 5,499 shares of the company's stock valued at $100,000 after purchasing an additional 5,197 shares during the period. Values First Advisors Inc. purchased a new stake in Privia Health Group during the third quarter worth about $83,000. Finally, Olympiad Research LP purchased a new stake in Privia Health Group during the third quarter worth about $195,000. Hedge funds and other institutional investors own 94.48% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.